Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL

NCT04548700 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

38

Enrollment

INDUSTRY

Sponsor class

Stopped The sponsor has adjusted its R\&D strategy.

Conditions

Treatment-naïve
Peripheral T Cell Lymphoma

Interventions

DRUG: Dose-finding stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone
DRUG: Dose-expansion stage: Liposomal mitoxantrone hydrochloride, Cyclophosphamide, Vincristine and Prednisone

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.